homocysteine has been researched along with pravastatin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blardi, P; De Lalla, A; Di Perri, T; Ghezzi, A; Volpi, L | 1 |
| Hayden, MR; Mujumdar, VS; Tyagi, SC | 1 |
| Dubská, L; Dvoráková, J; Hyánek, J; Táborský, L | 1 |
| Acampa, M; Capecchi, PL; Cuomo, A; Diciolla, F; Guideri, F; Laghi Pasini, F; Lazzerini, PE; Lisi, G; Maccherini, M; Toscano, M | 1 |
| Písaríková, A; Stanková, B; Tvrzická, E; Vecka, M; Zák, A; Zeman, M | 1 |
| Nanayakkara, PW; Scheffer, PG; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Dorp, W; van Guldener, C; van Ittersum, FJ | 1 |
| Chen, JW; Chen, YH; Huang, SL; Leu, HB; Lin, CP; Lin, WT; Liu, TZ | 1 |
| Blom, HJ; Kiefte-de Jong, JC; Kok, RM; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; ter Wee, PM; van Guldener, C; van Ittersum, FJ | 1 |
| Kiefte-de Jong, JC; Nanayakkara, PW; Olthof, MR; Smulders, YM; Stehouwer, CD; Teerlink, T; ter Wee, PM; Twisk, JW; van Guldener, C; van Ittersum, FJ | 1 |
| Nanayakkara, PW; Smulders, YM; Stehouwer, CD; ter Wee, PM; van Guldener, C; van Ittersum, FJ; Vegting, IL; Veringa, SJ | 1 |
| Assendelft, WJ; Blom, HJ; Blom, JW; de Craen, AJ; de Ruijter, W; Drewes, YM; Ford, I; Gussekloo, J; Poortvliet, RK; Sattar, N; Stott, DJ; Westendorp, RG; Wouter Jukema, J | 1 |
7 trial(s) available for homocysteine and pravastatin
| Article | Year |
|---|---|
[Effect of hypolipemic agents on levels of total plasma homocysteine].
Topics: Adolescent; Adult; Aged; Cholesterol; Female; Folic Acid; Homocysteine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6 | 2001 |
[Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
Topics: Adult; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Fenofibrate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Inflammation Mediators; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Single-Blind Method | 2005 |
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxid
Topics: Administration, Oral; Carotid Artery, Common; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Pravastatin; Pyridoxine; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Ultrasonography; Vitamin E; Vitamins | 2007 |
Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Topics: Adult; Carotid Arteries; DNA Methylation; Double-Blind Method; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Leukocytes; Male; Middle Aged; Pravastatin; Tunica Intima; Vitamin B Complex; Vitamin E | 2008 |
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Topics: Adult; Aged; Anticholesteremic Agents; Arginine; Carotid Arteries; Chronic Disease; Creatinine; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease.
Topics: Adult; Aged; Brachial Artery; Carotid Artery, Common; Chronic Disease; Double-Blind Method; Female; Femoral Artery; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Pravastatin; Vascular Stiffness; Vitamin E | 2012 |
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at Risk.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Netherlands; Pravastatin; Prospective Studies; Scotland; Survival Rate; Time Factors; Treatment Outcome | 2014 |
4 other study(ies) available for homocysteine and pravastatin
| Article | Year |
|---|---|
[Action of pravastatin treatment on blood levels of homocysteine].
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Time Factors | 1998 |
Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cells, Cultured; Collagen; Felodipine; Fluorescent Dyes; Fura-2; Glutathione; Homocysteine; Homocystine; Kinetics; Muscle, Smooth, Vascular; Neomycin; NG-Nitroarginine Methyl Ester; Pravastatin; Rats; Second Messenger Systems; Staurosporine; Tetradecanoylphorbol Acetate; Thapsigargin | 2000 |
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients.
Topics: Adult; Aged; Female; Heart Transplantation; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Retrospective Studies; Vitamins | 2002 |
Direct effect of statins on homocysteine-induced endothelial adhesiveness: potential impact to human atherosclerosis.
Topics: Aged; Anticholesteremic Agents; Case-Control Studies; Cell Adhesion; Cell Adhesion Molecules; Coronary Artery Disease; Endothelial Cells; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Middle Aged; Pravastatin; Simvastatin | 2008 |